CLINICAL_TRIALS
trial_result
· 2025-01-09
Clinical Trial Update: A Study of TAK-861 in Participants With Narcolepsy Type 2 [Phase 2]
Summary
Phase 2 study of TAK-861 in Narcolepsy Type 2 completed, with results posted by the sponsor.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Narcolepsy Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2025-01-09